Premium
O3‐04‐03: Tau splicing in vivo : Application in mouse models of tauopathy confers functional and pathological changes
Author(s) -
Schoch Kathleen M.,
DeVos Sarah L.,
Miller Rebecca L.,
Kebodeaux Carey S.,
Norrbom Michaela,
Chun Seung,
Dawson Ha.,
Rigo Frank,
Bennett C. Frank,
Miller Timothy M.
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.07.256
Subject(s) - tauopathy , rna splicing , exon , alternative splicing , gene isoform , tau protein , tau pathology , pathological , neuroscience , biology , medicine , endocrinology , microbiology and biotechnology , chemistry , alzheimer's disease , disease , neurodegeneration , rna , genetics , gene
Figure. Multip therapeutic int gions. Error rTg4510: * 1⁄4 0.0001. WT v rTg4510s. vs. INVESTIGATE NOVEL DRUG TREATMENT STRATEGIES IN MOUSE MODELS OF ALZHEIMER’S DISEASE Ozama Ismail, Holly Holmes, Niall Colgan, Da Ma, Jack A. Wells, Nicholas M. Powell, James M. O’Callaghan, Ian F. Harrison, Simon Walker-Samuel, Jorge M. Cardoso, Marc Modat, Elizabeth Fisher, Sebastien Ourselin, Tracey K. Murray, Zeshan Ahmed, Michael J. O’Neill, Ross A. Johnson, Emily C. Collins, Mark F. Lythgoe, University College London, London, United Kingdom; Centre for Medical Image Computing, University College London, London, United Kingdom; Eli Lilly and Company, Surrey, United Kingdom; Eli Lilly and Company, Indianapolis, IN, USA. Contact e-mail: o.ismail@ucl.ac.uk